MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

Stryker Corp

Затворен

СекторЗдравеопазване

368.07 -2.53

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

361.35

Максимум

377.22

Ключови измерители

By Trading Economics

Приходи

-288M

546M

Продажби

946M

6.4B

P/E

Средно за сектора

48.094

63.778

EPS

4.01

Дивидентна доходност

0.9

Марж на печалбата

8.484

Служители

53,000

EBITDA

385M

1.8B

Препоръки

By TipRanks

Препоръки

Силна покупка

12-месечна прогноза

+15.32% upside

Дивиденти

By Dow Jones

Дивидентна доходност

Средно за сектора

0.90%

2.39%

Следващи печалби

29.04.2025 г.

Следваща дата на дивидент

30.04.2025 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

-8.2B

142B

Предишно отваряне

370.6

Предишно затваряне

368.07

Настроения в новините

By Acuity

28%

72%

83 / 386 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Strong Bullish Evidence

Stryker Corp Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

28.01.2025 г., 21:55 ч. UTC

Печалби

Stryker Sees Further Organic Sales Growth in 2025

28.01.2025 г., 21:46 ч. UTC

Придобивния, сливания и поглъщания

Stryker to Sell Spinal Implants Business to Viscogliosi Brothers

6.01.2025 г., 22:18 ч. UTC

Придобивния, сливания и поглъщания

Stryker to Acquire Inari Medical in Deal Valued at $4.9 Billion -- Update

6.01.2025 г., 21:39 ч. UTC

Придобивния, сливания и поглъщания

Stryker to Acquire Inari Medical in Deal Valued at $4.9 Billion

19.02.2025 г., 13:53 ч. UTC

Придобивния, сливания и поглъщания

Stryker Files 8K - Asset Acquisition Or Disposition >SYK

19.02.2025 г., 13:30 ч. UTC

Придобивния, сливания и поглъщания

Stryker Completes Acquisition Of Inari Medical, Inc., Providing Entry Into The High-growth Peripheral Vascular Segment >SYK

28.01.2025 г., 21:09 ч. UTC

Придобивния, сливания и поглъщания

Stryker: Transaction Is Expected to Close in the U.S. in 1H 2025 >SYK

28.01.2025 г., 21:09 ч. UTC

Придобивния, сливания и поглъщания

Stryker: Agreement Includes Binding Offer to Acquire Stryker's Spinal Implants Business in France >SYK

28.01.2025 г., 21:08 ч. UTC

Придобивния, сливания и поглъщания

Stryker: After Closing, VB Spine Will Become a Strategic Partner to Stryker With Exclusive Access to Mako Spine and Copilot for Use With VB Spine's Implants in Spine Procedures >SYK

28.01.2025 г., 21:08 ч. UTC

Придобивния, сливания и поглъщания

Stryker: Agreement to Sell U.S. Spinal Implants Business to Viscogliosi Brothers, LLC to Create Newly Formed Co Called VB Spine, LLC >SYK

28.01.2025 г., 21:06 ч. UTC

Печалби

Stryker Sees Organic Net Sales Growth of 8% to 9% for 2025 >SYK

28.01.2025 г., 21:06 ч. UTC

Печалби

Stryker Sees FY Adj EPS $13.45-Adj EPS $13.70 >SYK

28.01.2025 г., 21:05 ч. UTC

Придобивния, сливания и поглъщания

Stryker: Announces Definitive Agreement for the Sale of U.S. Spinal Implants Business and Plans to Sell Related Intl Business

28.01.2025 г., 21:05 ч. UTC

Печалби

Stryker 4Q Net $500M >SYK

28.01.2025 г., 21:05 ч. UTC

Печалби

Stryker 4Q Adj EPS $4.01 >SYK

28.01.2025 г., 21:05 ч. UTC

Печалби

Stryker 4Q Net $546M >SYK

28.01.2025 г., 21:05 ч. UTC

Печалби

Stryker 4Q Net $500M >SYK

28.01.2025 г., 21:05 ч. UTC

Печалби

Stryker 4Q Sales $6.4B >SYK

28.01.2025 г., 21:05 ч. UTC

Печалби

Stryker 4Q EPS $1.41 >SYK

28.01.2025 г., 21:05 ч. UTC

Печалби

Stryker 4Q Adj EPS $4.01 >SYK

28.01.2025 г., 21:05 ч. UTC

Печалби

Stryker 4Q EPS $1.41 >SYK

28.01.2025 г., 21:05 ч. UTC

Печалби

Stryker 4Q Sales $6.4B >SYK

17.01.2025 г., 21:20 ч. UTC

Придобивния, сливания и поглъщания

Stryker Commences Tender Offer for All Outstanding Shrs of Common Stock of Inari Medical

13.01.2025 г., 19:30 ч. UTC

Печалби

Update: Stryker Had A Good Year Last Year; Here's How It's Looking For 2025 -- IBD

7.01.2025 г., 09:58 ч. UTC

Горещи акции

Stocks to Watch Tuesday: Nvidia, Uber, Tencent -- WSJ

6.01.2025 г., 22:03 ч. UTC

Топ новини
Придобивния, сливания и поглъщания

Stryker to Acquire Inari Medical in Deal Valued at $4.9B -- Update

6.01.2025 г., 21:49 ч. UTC

Придобивния, сливания и поглъщания

Inari Medical Catapults -- Again -- After Stryker Confirms $4.9 Billion Deal -- IBD

6.01.2025 г., 21:24 ч. UTC

Топ новини
Придобивния, сливания и поглъщания

Stryker to Acquire Inari Medical in Deal Valued at $4.9B

6.01.2025 г., 21:11 ч. UTC

Придобивния, сливания и поглъщания

Stryker: Inari's Innovative Pdt Portfolio Is Highly Complementary to Our Neurovascular Business >SYK

6.01.2025 г., 21:10 ч. UTC

Придобивния, сливания и поглъщания

Stryker: Transaction Is Anticipated to Close by the End of the 1Q >SYK

Сравнение с други в отрасъла

Ценова промяна

Stryker Corp Прогноза

Ценова цел

By TipRanks

15.32% нагоре

12-месечна прогноза

Среден 435.3 USD  15.32%

Висок 465 USD

Нисък 400 USD

Според 22 анализатори от Wall Street, предложили 12-месечна ценова цел за Stryker Corp през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

22 ratings

18

Купи

4

Задържане

0

Продай

Техническа оценка

By Trading Central

374.61 / 378.05Подкрепа & съпротива

Краткосрочен план

Strong Bullish Evidence

Средносрочен план

Bearish Evidence

Дългосрочен план

Neutral Evidence

Настроение

By Acuity

83 / 386 Класиране в Здравеопазване

Настроения в новините

Бичи доказателства

Волатилност

Под средното

Обем новини (RCV)

Над средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Stryker Corp

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.